Characteristic variations of serum alkaline DNase activity in relation to response to therapy and tumor prognosis in human lung cancer.
(1988) European Journal of Cancer and Clinical Oncology — Vol. 24, n° 8, p. 1337-1343 (1988)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- The objective of the present study was to evaluate serum alkaline DNase activity (SADA) variations as a useful means of lung cancer monitoring therapy. SADA was measured in 40 patients with non-small cell and small cell carcinomas. Blood samples were collected before (Time 0), during the treatment and months after therapy. A decrease in SADA during the first treatment indicates a good clinical response, whereas an absence of decrease indicates a non-response to treatment. In patients who respond to therapy, three types of variations of SADA are observed during the clinical course. A progressive regaining of SADA up to a value largely exceeding the level of the initial SADA value (T0) correlates with a complete remission. An incomplete regaining of enzyme activity corresponds to a partial remission, whereas no regaining of SADA precedes a fatal evolution. Such variations in SADA observed in the 40 patients with lung carcinomas support our previously published clinical results, confirming that the variations of SADA could be a reliable marker for the therapeutic monitoring of different human malignancies.
- Affiliations
Citations
Economidou-Karaoglou, A., Opsomer, M., Petit, G., Lans, M., Taper, H., & Roberfroid, M. (1988). Characteristic variations of serum alkaline DNase activity in relation to response to therapy and tumor prognosis in human lung cancer. European Journal of Cancer and Clinical Oncology, 24(8), 1337-1343. https://doi.org/10.1016/0277-5379(88)90225-8 (Original work published 1988)